Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

DoorDash Buys Deliveroo: A Game Changer?

DoorDash is stepping into new frontiers, buying the British Deliveroo to bolster its ambitions abroad. The deal could add upside to shares long-term.

Is Netflix's Ad Deal With Amazon the Catalyst for a New Uptrend?

Is Netflix's Ad Deal With Amazon the Catalyst for a New Uptrend?

Netflix announced a new advertising deal with Amazon, opening up a new revenue source for the world's top streamer. Is this the next catalyst for NFLX shares?

Clearway Energy’s Price Dip: 3 Reasons It’s a Signal to Buy

Clearway Energy’s Price Dip: 3 Reasons It’s a Signal to Buy

Clearway Energy has a clear pathway to growth that supports its robust dividend and distribution growth outlook: analysts and institutions are buying it.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Biotech Breakouts: 3 Stocks With Massive Upside Potential

Biotech stocks are highly volatile; however, these biotech stocks have key trial results this fall that could spark sharp moves and long-term growth potential

Powering Up: A Buy Rating Signals GE Vernova's AI Tailwinds

A recent analyst upgrade to Buy highlights GE Vernova’s critical role in powering the AI revolution as demand for energy and grid infrastructure soars.

The Side of Rate Cuts Nobody Is Telling You About

This is the side of rate cuts that nobody is talking about. There will be a likely rotation after one big blow off top, but not where you think it will.

Dave & Buster’s Stock: Is Now the Time to Make a PLAY?

Dave & Buster's turnaround gains traction with the hiring of a new CEO: Tarun Lal has decades of experience with KFC and is well-suited to the task.

inkl

Read news from The Economist, FT, and more,
with one subscription

Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing?

Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing?

Nike has been battered, but a run of analyst upgrades and signs of improving fundamentals suggest a comeback rally could be brewing.

Meta Slips as Oracle Surges: ORCL's AI Outlook Bearish for Meta?

Meta Slips as Oracle Surges: ORCL's AI Outlook Bearish for Meta?

On Sept. 10, Meta Platforms suffered as Oracle soared 36%. Is Oracle's shocking cloud infrastructure guidance a warning sign for Meta?

Broadcom Hits Record High After CEO Hock Tan AI Pay Package

Broadcom Hits Record High After CEO Hock Tan AI Pay Package

See why Broadcom gained another 9.8% after its impressive earnings report that also sent shares flying. Are the signals surrounding its CEO bullish or bearish?

The Most Upgraded Stocks in Q3: Good News for the S&P 500

The Most Upgraded Stocks in Q3: Good News for the S&P 500

Investors should take note of changes in MarketBeat's list of Most Upgraded Stocks, which indicates the AI market leaders are back in favor among analysts.

Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors

Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors

CoreWeave's strategic partnership with Nvidia provides a revenue backstop, cementing its status as a premier builder of the AI industry's foundation.

CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges

CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges

CrowdStrike's partnerships with Salesforce and NVIDIA make it a cybersecurity leader for agentic AI, with stock testing key resistance

This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge

This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge

Oracle's new earnings breakout suggests that Taiwan Semiconductor should follow suit as the root provider of this new infrastructure growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

This Defense Stock Is Up 113% This Year—Is It Still a Buy?

In just seven months after its IPO, defense stock Karman is providing early investors with huge returns. Raymond James sees over 50% more upside still to come.

Rezolute Stock: FDA Fast Track Fuels 2025 Breakout

Rezolute, Inc. is on track for its lead candidate to hit blockbuster status, but there are still risks and hurdles to overcome.

Is It Time to Trim Your Positions in These 2 AI Stocks?

AI stocks continue to propel the major indices to record highs. But surging valuations are concerning, and investors may want to lock in gains.

These 3 Tech Stocks Just Supercharged Their Buybacks

Check out these three tech stocks that just significantly increased their buyback capacity, including one of the world's biggest names in software.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Dividend Stocks to Hold Through Market Volatility This Fall

Interest rate cuts may not decrease market volatility; discover three dividend stocks that can deliver stability, income, and growth during this fall

Resideo Technologies: Institutional Activity Signals 30% Upside

Resideo Technologies' stock price is poised to surge higher now that it has crossed a critical inflection point, with triple-digit gains within reach.

2 Falling Knives That Might Be Worth Catching

The Trade Desk and Duolingo have each plunged nearly 50% in recent months, but contrarian investors may see an opportunity in these beaten-down stocks.

Uranium Energy Stock Has Momentum—and More Upside Ahead

The shift into nuclear energy is going to accelerate out of necessity in the coming years, which is where Uranium Energy stock comes into play.

If a Recession Is Coming, You'll Want to Own These 2 Stocks

With the economy flirting with a recession, investors who shore up their portfolios with defensive consumer staples stocks are likely to feel less pain.

3 Under-the-Radar Stocks Set to Benefit From Oracle’s Boom

Oracle just provided an outlook on its artificial intelligence-driven business that shocked markets in a great way. These three stocks can benefit.

Lululemon’s Sell-Off Looks Overdone: A Contrarian Case

Lululemon has been continuously dumped by investors, but there's a sense the worst-case scenario is priced in and the risk/reward setup is attractive.

1 … 66 67 68 69

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

347,854 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play